<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01209988</url>
  </required_header>
  <id_info>
    <org_study_id>AMC_UR_010</org_study_id>
    <nct_id>NCT01209988</nct_id>
  </id_info>
  <brief_title>Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy</brief_title>
  <official_title>A Prospective Randomized Study Examining the Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-Assisted Laparoscopic Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Astellas Pharma Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To date, there is a lack of consensus concerning the optimal timing for removal of the
      urethral catheter, its related complications, the effectiveness in prophylactic drug use to
      reduce complication, and the patient reported outcomes (quality of life) after robot-assisted
      laparoscopic prostatectomy (RALP). The purpose of this study is to determine the impact of
      tamsulosin on voiding patterns following early urethral catheter removal after RALP for
      prostate cancer.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of acute urinary retention</measure>
    <time_frame>within the 30 days after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient reported outcomes</measure>
    <time_frame>20 days after surgery (plus or minus 3 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Prostatic Neoplasms, Prostatectomy</condition>
  <arm_group>
    <arm_group_label>Tamsulosin 0.4mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Perioperative tamsulosin 0.4mg daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No medication</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tamsulosin 0.4mg</intervention_name>
    <description>perioperative tamsulosin 0.4mg daily for three weeks</description>
    <arm_group_label>Tamsulosin 0.4mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No medication</intervention_name>
    <description>No medication</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must have localized or locally advanced prostate cancer

          -  Patients must receive robot assisted laparoscopic radical prostatectomy

          -  Patients must be able to provide written informed consent

        Exclusion Criteria:

          -  Patients must not have a history of treatment with alpha blockers within 4 weeks

          -  Patients must not have previously undergone transurethral resection, laser therapy, or
             other surgery of the prostate

          -  Patients must not have previously been diagnosed with neurogenic bladder

          -  Patients must not have hypersensitivity to trial drug or other alpha-blockers

          -  Patients must not have the participation of other clinical trial within the past 3
             months
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Choung-Soo Kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Urology, Asan Medical Center, Seoul, Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Choung-Soo Kim, M.D.</last_name>
    <phone>82-2-3010-3734</phone>
    <email>cskim@amc.seoul.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Choung-Soo Kim, M.D.</last_name>
      <email>cskim@amc.seoul.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2010</study_first_submitted>
  <study_first_submitted_qc>September 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2010</study_first_posted>
  <last_update_submitted>September 27, 2010</last_update_submitted>
  <last_update_submitted_qc>September 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Choung-Soo Kim/professor</name_title>
    <organization>Asan Medical Center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tamsulosin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

